Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hannes Muehleisen"'
Autor:
Romana Gugenberger, Alexander Dohnal, Kathrin Thell, Sarah Bischof, Mario Kuttke, Bernhard Peball, Hannes Muehleisen, Maria Urban, Andreas Tanzmann, Beate Pribitzer, Felix Batrina, Stefan Bunka, Sophia Spagl, Manuela Branka, Markus Raderer, Gerald Prager, Thorsten Fuereder, Nina Worel
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::323d591adb560e8848b2d43c36bd5603
https://doi.org/10.1136/jitc-2022-sitc2022.0722
https://doi.org/10.1136/jitc-2022-sitc2022.0722
Autor:
Romana Gugenberger, Alexander Dohnal, Andreas Tanzmann, Beate Pribitzer, Felix Batrina, Stefan Bunka, Sophia Spagl, Manuela Branka, Sarah Bischof, Kathrin Thell, Mario Kuttke, Maria Urban, Hannes Muehleisen, Bernhard Peball, Markus Raderer, Gerald Prager, Nina Worel
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94afcc28113a53093b2d7248ce77ee18
https://doi.org/10.1136/jitc-2022-sitc2022.0653
https://doi.org/10.1136/jitc-2022-sitc2022.0653
Autor:
Mario Kuttke, Alexander Dohnal, Andreas Tanzmann, Beate Pribitzer, Felix Batrina, Stefan Bunka, Sophia Spagl, Manuela Branka, Sarah Bischof, Kathrin Thell, Maria Urban, Hannes Muehleisen, Bernhard Peball, Bianca Gapp, Angela Halfmann, Markus Raderer, Gerald Prager, Thorsten Fuereder, Romana Gugenberger, Nina Worel
Publikováno v:
Cancer Research. 83:LB187-LB187
Immune checkpoint control is one of several mechanisms that negatively influence the immune system and contribute to the development and progression of cancer. To enhance anti-tumor immune responses in patients with advanced solid tumors, we employ a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f77d9b734993dd9e5119fc18a9e3acaf
https://doi.org/10.1158/1538-7445.am2023-lb187
https://doi.org/10.1158/1538-7445.am2023-lb187
Autor:
Alexander B. Dohnal, Hannes Muehleisen, Anthony B. El-Khoueiry, Romana Gugenberger, Carlos Becerra, Josef M. Penninger, Karin Drobits, Vincent Chung, Julia Harrauer, Maria Urban, Guenther Lametschwandtner, Isabella Haslinger, Anderson Gaweco, Kathrin Thell
Publikováno v:
Molecular Cancer Therapeutics. 18:C048-C048
Introduction: The E3 ubiquitin ligase Cbl-b is an intracellular master checkpoint which negatively regulates both adaptive and innate anti-tumor immune responses. Selective targeting of Cbl-b not only induces anti-tumor activity in vivo but also over
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9ec0dd545696ceb823ce03d39ea4d90
https://doi.org/10.1158/1535-7163.targ-19-c048
https://doi.org/10.1158/1535-7163.targ-19-c048